Article Details

Fortress Biotech, Inc. (NASDAQ:FBIO) Given Average Rating of "Buy" by Analysts

Retrieved on: 2021-02-22 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Fortress Biotech, Inc. (NASDAQ:FBIO) Given Average Rating of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 4,559,127 shares of the biopharmaceutical company's stock worth $18,419,000 after purchasing an additional 567,911 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up